Viela Bio
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland.
Industries
biopharma
biotechnology
health-diagnostics
medical
wellness
Nr. of Employees
medium (51-250)
Patents
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases
US-12209123-B2
View DetailsMethods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer
US-11555062-B2
View DetailsNucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit
US-11104720-B2
View Details
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases
US-12209123-B2
View DetailsMethods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer
US-11555062-B2
View DetailsNucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit
US-11104720-B2
View Details